New strategies in the management of children and adolescents with proliferative lupus nephritis

Keith K. Lau, Maha Haddad, Lavjay Butani

Research output: Contribution to journalArticle

Abstract

Systemic hipus erythematosus (SLE) is a serious medical illness with frequent renal-involvement at disease onset. Although predominantly affecting young women, SLE often first presents during childhood. Previous studies have suggested that patients with disease onset in childhood have a worse prognosis. Renal involvement in SLE is the major determinant of long-term outcome; the ten-year survival in children with lupus-nephritis was only around 20% in late 60s, but outcomes have improved dramatically in recent years to around 94%. This article will review recent data on new approaches in the treatment of pediatric lupus nephritis by referencing the major studies over the last few years. We will also examine the validity of various factors that have been suggested by previous studies to have prognostic value in determining outcomes.

Original languageEnglish (US)
Pages (from-to)280-286
Number of pages7
JournalCurrent Rheumatology Reviews
Volume3
Issue number4
DOIs
StatePublished - Nov 2007

Fingerprint

Lupus Nephritis
Kidney
Pediatrics
Survival
Therapeutics

Keywords

  • Lupus
  • Nephritis
  • Outcomes
  • Pediatric
  • SLE
  • Therapy

ASJC Scopus subject areas

  • Rheumatology

Cite this

New strategies in the management of children and adolescents with proliferative lupus nephritis. / Lau, Keith K.; Haddad, Maha; Butani, Lavjay.

In: Current Rheumatology Reviews, Vol. 3, No. 4, 11.2007, p. 280-286.

Research output: Contribution to journalArticle

@article{eb501ad03c3e45b7808c03d8c601afb9,
title = "New strategies in the management of children and adolescents with proliferative lupus nephritis",
abstract = "Systemic hipus erythematosus (SLE) is a serious medical illness with frequent renal-involvement at disease onset. Although predominantly affecting young women, SLE often first presents during childhood. Previous studies have suggested that patients with disease onset in childhood have a worse prognosis. Renal involvement in SLE is the major determinant of long-term outcome; the ten-year survival in children with lupus-nephritis was only around 20{\%} in late 60s, but outcomes have improved dramatically in recent years to around 94{\%}. This article will review recent data on new approaches in the treatment of pediatric lupus nephritis by referencing the major studies over the last few years. We will also examine the validity of various factors that have been suggested by previous studies to have prognostic value in determining outcomes.",
keywords = "Lupus, Nephritis, Outcomes, Pediatric, SLE, Therapy",
author = "Lau, {Keith K.} and Maha Haddad and Lavjay Butani",
year = "2007",
month = "11",
doi = "10.2174/157339707782409008",
language = "English (US)",
volume = "3",
pages = "280--286",
journal = "Current Rheumatology Reviews",
issn = "1573-3971",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - New strategies in the management of children and adolescents with proliferative lupus nephritis

AU - Lau, Keith K.

AU - Haddad, Maha

AU - Butani, Lavjay

PY - 2007/11

Y1 - 2007/11

N2 - Systemic hipus erythematosus (SLE) is a serious medical illness with frequent renal-involvement at disease onset. Although predominantly affecting young women, SLE often first presents during childhood. Previous studies have suggested that patients with disease onset in childhood have a worse prognosis. Renal involvement in SLE is the major determinant of long-term outcome; the ten-year survival in children with lupus-nephritis was only around 20% in late 60s, but outcomes have improved dramatically in recent years to around 94%. This article will review recent data on new approaches in the treatment of pediatric lupus nephritis by referencing the major studies over the last few years. We will also examine the validity of various factors that have been suggested by previous studies to have prognostic value in determining outcomes.

AB - Systemic hipus erythematosus (SLE) is a serious medical illness with frequent renal-involvement at disease onset. Although predominantly affecting young women, SLE often first presents during childhood. Previous studies have suggested that patients with disease onset in childhood have a worse prognosis. Renal involvement in SLE is the major determinant of long-term outcome; the ten-year survival in children with lupus-nephritis was only around 20% in late 60s, but outcomes have improved dramatically in recent years to around 94%. This article will review recent data on new approaches in the treatment of pediatric lupus nephritis by referencing the major studies over the last few years. We will also examine the validity of various factors that have been suggested by previous studies to have prognostic value in determining outcomes.

KW - Lupus

KW - Nephritis

KW - Outcomes

KW - Pediatric

KW - SLE

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=36348938802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36348938802&partnerID=8YFLogxK

U2 - 10.2174/157339707782409008

DO - 10.2174/157339707782409008

M3 - Article

AN - SCOPUS:36348938802

VL - 3

SP - 280

EP - 286

JO - Current Rheumatology Reviews

JF - Current Rheumatology Reviews

SN - 1573-3971

IS - 4

ER -